NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

關節內粘稠補充療法的全球市場:各產品的預測(到2025年)- COVID-19累積的影響

Viscosupplementation Market Research Report by Product (Five Injection, Single Injection, and Three Injection), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1001099
出版日期 內容資訊 英文 185 Pages
商品交期: 最快1-2個工作天內
價格
關節內粘稠補充療法的全球市場:各產品的預測(到2025年)- COVID-19累積的影響 Viscosupplementation Market Research Report by Product (Five Injection, Single Injection, and Three Injection), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 185 Pages
簡介

全球關節內粘稠補充療法的市場規模預測將從2020年的23億9,451萬美元,擴大到2025年末的30億7,705萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察。

本報告提供全球關節內粘稠補充療法市場的相關調查,提供市場機會和課題,成長及阻礙因素,COVID-19累積的影響,產品·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查期間
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 製作計劃:調查計劃
    • 實施實行:調查
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 市場展望
  • 各產品市場展望
  • 各地區市場的展望
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析

第6章 各產品市場

  • 5次注射
  • 單回注射
  • 3次注射

第7章 南北美洲市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第8章 亞太地區市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第9章 歐洲,中東·非洲市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第10章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併·收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 評估,認識,擴大

第11章 企業簡介

  • Alcon Vision LLC
  • Allergan, Inc.
  • Anika Therapeutics, Inc.
  • Bausch Health Companies Inc
  • Bioventus LLC
  • Chugai Pharmaceutical Co., Ltd.
  • Contipro A.S.
  • F. Hoffmann-La Roche AG
  • Ferring B.V.
  • Fidia Farmaceutici S.P.A.
  • Galderma Laboratories, L.P.
  • Johnson & Johnson Services, Inc
  • LG Life Sciences Ltd
  • Lifecore Biomedical, LLC
  • Mylan N.V.
  • OrthogenRx, Inc
  • Regen Lab SA
  • Salix Pharmaceuticals, Inc.
  • Sanofi S.A.
  • Seikagaku Corporation
  • Smith & Nephew Plc
  • Teva Pharmaceutical Industries Ltd
  • Zimmer Biomet

第12章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-0315DDADCE20

The Global Viscosupplementation Market size was estimated at USD 2,394.51 Million in 2020 and expected to reach USD 2,529.65 Million in 2021, at a Compound Annual Growth Rate (CAGR) 5.98% to reach USD 3,393.24 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Viscosupplementation to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Viscosupplementation Market was studied across Five Injection, Single Injection, and Three Injection.

Based on Geography, the Viscosupplementation Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Viscosupplementation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Viscosupplementation Market, including Alcon Vision LLC, Allergan, Inc., Anika Therapeutics, Inc., Bausch Health Companies Inc, Bioventus LLC, Chugai Pharmaceutical Co., Ltd., Contipro A.S., F. Hoffmann-La Roche AG, Ferring B.V., Fidia Farmaceutici S.P.A., Galderma Laboratories, L.P., Johnson & Johnson Services, Inc, LG Life Sciences Ltd, Lifecore Biomedical, LLC, Mylan N.V., OrthogenRx, Inc, Regen Lab SA, Salix Pharmaceuticals, Inc., Sanofi S.A., Seikagaku Corporation, Smith & Nephew Plc, Teva Pharmaceutical Industries Ltd, and Zimmer Biomet.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Viscosupplementation Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Viscosupplementation Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Viscosupplementation Market?
  • 4. What is the competitive strategic window for opportunities in the Global Viscosupplementation Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Viscosupplementation Market?
  • 6. What is the market share of the leading vendors in the Global Viscosupplementation Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Viscosupplementation Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Product Outlook
  • 3.4. Geography Outlook
  • 3.5. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need for non-surgical treatment for osteoarthritis
      • 5.1.1.2. Rising occurrence of lifestyle-induced disorders with changing eating habits
      • 5.1.1.3. Surge in geriatric population and obesity globally
    • 5.1.2. Restraints
      • 5.1.2.1. Dearth of efficiency and product safety
      • 5.1.2.2. High cost of the hyaluronic acid-based treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in the development of hyaluronic acid-based therapies
      • 5.1.3.2. Increasing research and development for product expansion
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory mandates for approval coupled with short duration of lubrication and pain relief
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Viscosupplementation Market, by Product

  • 6.1. Introduction
  • 6.2. Five Injection
  • 6.3. Single Injection
  • 6.4. Three Injection

7. Americas Viscosupplementation Market

  • 7.1. Introduction
  • 7.2. Argentina
  • 7.3. Brazil
  • 7.4. Canada
  • 7.5. Mexico
  • 7.6. United States
    • 7.6.1. California
    • 7.6.2. Florida
    • 7.6.3. Illinois
    • 7.6.4. New York
    • 7.6.5. Ohio
    • 7.6.6. Pennsylvania
    • 7.6.7. Texas

8. Asia-Pacific Viscosupplementation Market

  • 8.1. Introduction
  • 8.2. China
  • 8.3. India
  • 8.4. Indonesia
  • 8.5. Japan
  • 8.6. Malaysia
  • 8.7. Philippines
  • 8.8. South Korea
  • 8.9. Thailand

9. Europe, Middle East & Africa Viscosupplementation Market

  • 9.1. Introduction
  • 9.2. France
  • 9.3. Germany
  • 9.4. Italy
  • 9.5. Netherlands
  • 9.6. Qatar
  • 9.7. Russia
  • 9.8. Saudi Arabia
  • 9.9. South Africa
  • 9.10. Spain
  • 9.11. United Arab Emirates
  • 9.12. United Kingdom

10. Competitive Landscape

  • 10.1. FPNV Positioning Matrix
    • 10.1.1. Quadrants
    • 10.1.2. Business Strategy
    • 10.1.3. Product Satisfaction
  • 10.2. Market Ranking Analysis
  • 10.3. Market Share Analysis, By Quadrant
  • 10.4. Market Share Analysis, By Company
  • 10.5. Competitive Scenario
    • 10.5.1. Merger & Acquisition
    • 10.5.2. Agreement, Collaboration, & Partnership
    • 10.5.3. New Product Launch & Enhancement
    • 10.5.4. Investment & Funding
    • 10.5.5. Award, Recognition, & Expansion

11. Company Usability Profiles

  • 11.1. Alcon Vision LLC
  • 11.2. Allergan, Inc.
  • 11.3. Anika Therapeutics, Inc.
  • 11.4. Bausch Health Companies Inc
  • 11.5. Bioventus LLC
  • 11.6. Chugai Pharmaceutical Co., Ltd.
  • 11.7. Contipro A.S.
  • 11.8. F. Hoffmann-La Roche AG
  • 11.9. Ferring B.V.
  • 11.10. Fidia Farmaceutici S.P.A.
  • 11.11. Galderma Laboratories, L.P.
  • 11.12. Johnson & Johnson Services, Inc
  • 11.13. LG Life Sciences Ltd
  • 11.14. Lifecore Biomedical, LLC
  • 11.15. Mylan N.V.
  • 11.16. OrthogenRx, Inc
  • 11.17. Regen Lab SA
  • 11.18. Salix Pharmaceuticals, Inc.
  • 11.19. Sanofi S.A.
  • 11.20. Seikagaku Corporation
  • 11.21. Smith & Nephew Plc
  • 11.22. Teva Pharmaceutical Industries Ltd
  • 11.23. Zimmer Biomet

12. Appendix

  • 12.1. Discussion Guide
  • 12.2. License & Pricing
  • 12.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL VISCOSUPPLEMENTATION MARKET: MARKET DYNAMICS
  • FIGURE 5. GLOBAL VISCOSUPPLEMENTATION MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
  • FIGURE 8. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, 2018-2026 (USD MILLION)
  • FIGURE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 16. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 18. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 19. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 20. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 21. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 22. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 23. CALIFORNIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 24. FLORIDA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 25. ILLINOIS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 26. NEW YORK VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 27. OHIO VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 28. PENNSYLVANIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 29. TEXAS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 30. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 31. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 33. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 42. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 44. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. GLOBAL VISCOSUPPLEMENTATION MARKET: FPNV POSITIONING MATRIX
  • FIGURE 56. GLOBAL VISCOSUPPLEMENTATION MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 57. GLOBAL VISCOSUPPLEMENTATION MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 58. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL VISCOSUPPLEMENTATION MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL VISCOSUPPLEMENTATION MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. CALIFORNIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. FLORIDA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. ILLINOIS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. NEW YORK VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. OHIO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. PENNSYLVANIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. TEXAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. GLOBAL VISCOSUPPLEMENTATION MARKET: SCORES
  • TABLE 46. GLOBAL VISCOSUPPLEMENTATION MARKET: BUSINESS STRATEGY
  • TABLE 47. GLOBAL VISCOSUPPLEMENTATION MARKET: PRODUCT SATISFACTION
  • TABLE 48. GLOBAL VISCOSUPPLEMENTATION MARKET: RANKING
  • TABLE 49. GLOBAL VISCOSUPPLEMENTATION MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 50. GLOBAL VISCOSUPPLEMENTATION MARKET: SHARE, BY COMPANY, 2020
  • TABLE 51. GLOBAL VISCOSUPPLEMENTATION MARKET: MERGER & ACQUISITION
  • TABLE 52. GLOBAL VISCOSUPPLEMENTATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 53. GLOBAL VISCOSUPPLEMENTATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 54. GLOBAL VISCOSUPPLEMENTATION MARKET: INVESTMENT & FUNDING
  • TABLE 55. GLOBAL VISCOSUPPLEMENTATION MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 56. GLOBAL VISCOSUPPLEMENTATION MARKET: LICENSE & PRICING
  • TABLE 57. GLOBAL VISCOSUPPLEMENTATION MARKET: CONTACT DETAILS